CN116889528A - Water-light mask and preparation method thereof - Google Patents
Water-light mask and preparation method thereof Download PDFInfo
- Publication number
- CN116889528A CN116889528A CN202310853358.8A CN202310853358A CN116889528A CN 116889528 A CN116889528 A CN 116889528A CN 202310853358 A CN202310853358 A CN 202310853358A CN 116889528 A CN116889528 A CN 116889528A
- Authority
- CN
- China
- Prior art keywords
- extract
- mask
- hydrographic
- skin
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 229920001184 polypeptide Polymers 0.000 claims abstract description 24
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 24
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 24
- -1 skin conditioner Substances 0.000 claims abstract description 14
- 230000001815 facial effect Effects 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims abstract description 11
- 108010087806 Carnosine Proteins 0.000 claims abstract description 11
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims abstract description 11
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims abstract description 11
- 229940044199 carnosine Drugs 0.000 claims abstract description 11
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims abstract description 10
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 10
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 239000000419 plant extract Substances 0.000 claims abstract description 9
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims abstract description 8
- 239000004909 Moisturizer Substances 0.000 claims abstract description 8
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims abstract description 8
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims abstract description 8
- 230000001333 moisturizer Effects 0.000 claims abstract description 8
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 8
- SCAKQYSGEIHPLV-IUCAKERBSA-N (4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-(carboxymethylcarbamoyl)pyrrolidin-1-yl]-5-oxopentanoic acid Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SCAKQYSGEIHPLV-IUCAKERBSA-N 0.000 claims abstract description 7
- 230000002421 anti-septic effect Effects 0.000 claims abstract 2
- 239000000284 extract Substances 0.000 claims description 26
- 239000003906 humectant Substances 0.000 claims description 17
- 239000003995 emulsifying agent Substances 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 239000000341 volatile oil Substances 0.000 claims description 6
- 230000003750 conditioning effect Effects 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000012875 nonionic emulsifier Substances 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 150000003384 small molecules Chemical class 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 3
- 229940018958 sargassum fusiforme extract Drugs 0.000 claims description 3
- 108700004714 Gelonium multiflorum GEL Proteins 0.000 claims description 2
- 239000005515 coenzyme Substances 0.000 claims description 2
- 229940064064 purslane extract Drugs 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 241000512259 Ascophyllum nodosum Species 0.000 claims 1
- 241000167550 Centella Species 0.000 claims 1
- 235000005205 Pinus Nutrition 0.000 claims 1
- 241000218602 Pinus <genus> Species 0.000 claims 1
- 244000046146 Pueraria lobata Species 0.000 claims 1
- 235000010575 Pueraria lobata Nutrition 0.000 claims 1
- 241001145025 Saussurea involucrata Species 0.000 claims 1
- 229940069521 aloe extract Drugs 0.000 claims 1
- 229940065115 grapefruit extract Drugs 0.000 claims 1
- 229940094952 green tea extract Drugs 0.000 claims 1
- 235000020688 green tea extract Nutrition 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 10
- 239000000047 product Substances 0.000 description 46
- 210000003491 skin Anatomy 0.000 description 35
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 19
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 230000037394 skin elasticity Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 5
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 5
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 235000011941 Tilia x europaea Nutrition 0.000 description 5
- 239000010627 cedar oil Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 5
- 239000004571 lime Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 229940015975 1,2-hexanediol Drugs 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 235000011399 aloe vera Nutrition 0.000 description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 229920000058 polyacrylate Polymers 0.000 description 4
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 4
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 4
- 229940113124 polysorbate 60 Drugs 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 244000146462 Centella asiatica Species 0.000 description 3
- 235000004032 Centella asiatica Nutrition 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- YPUZOECTETYPRF-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine-2-carboxylic acid Chemical compound OC(=O)C1NCC=CN1 YPUZOECTETYPRF-UHFFFAOYSA-N 0.000 description 2
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 2
- 241001116389 Aloe Species 0.000 description 2
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- 241001512722 Ecklonia cava Species 0.000 description 2
- 235000007270 Gaultheria hispida Nutrition 0.000 description 2
- 241000206672 Gelidium Species 0.000 description 2
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 2
- 235000009134 Myrica cerifera Nutrition 0.000 description 2
- 244000269152 Myrica pensylvanica Species 0.000 description 2
- 235000012851 Myrica pensylvanica Nutrition 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- 229940080421 coco glucoside Drugs 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 description 1
- GFLJSOROHICWQL-KBPBESRZSA-N (2s)-2-[[(2s)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)C)CC1=CC=C(O)C=C1 GFLJSOROHICWQL-KBPBESRZSA-N 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- QGGBBQJHVCVVKM-XOBYPWAZSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-amino-3-carboxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amin Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(N)=O QGGBBQJHVCVVKM-XOBYPWAZSA-N 0.000 description 1
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 1
- UIEVCEQLNUHDIF-UHFFFAOYSA-N 1-chloro-2,4-dimethylbenzene Chemical group CC1=CC=C(Cl)C(C)=C1 UIEVCEQLNUHDIF-UHFFFAOYSA-N 0.000 description 1
- GJYCVCVHRSWLNY-UHFFFAOYSA-N 2-butylphenol Chemical compound CCCCC1=CC=CC=C1O GJYCVCVHRSWLNY-UHFFFAOYSA-N 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000156948 Aphantopus hyperantus Species 0.000 description 1
- 241001530056 Athelia rolfsii Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- KNFLNGRLKALWRF-LDXSYGEZSA-N CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 KNFLNGRLKALWRF-LDXSYGEZSA-N 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000000882 Citrus x paradisi Nutrition 0.000 description 1
- 241000113542 Codium tomentosum Species 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 101000761020 Dinoponera quadriceps Poneritoxin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000206671 Gelidium amansii Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 101000578920 Homo sapiens Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 Proteins 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102100028322 Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 Human genes 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- 235000008582 Pinus sylvestris Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000264279 Sargassum fusiforme Species 0.000 description 1
- 241000133134 Saussurea Species 0.000 description 1
- 241000488874 Sonchus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940078033 acetyl octapeptide-3 Drugs 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- 229960002798 cetrimide Drugs 0.000 description 1
- 229960002242 chlorocresol Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000001896 cresols Chemical class 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 229960004867 hexetidine Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940094946 palmitoyl tetrapeptide-7 Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 108010030856 phenylalanyl-glycyl-valyl-statyl-alanyl-phenylalanine methyl ester Proteins 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000001839 pinus sylvestris Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 239000003009 skin protective agent Substances 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The invention discloses a water-light facial mask and a preparation method thereof, wherein the preparation raw materials comprise: water, moisturizer, skin conditioner, antioxidant component, plant extract, skin protectant, film forming agent, pH regulator, and antiseptic. The polypeptide combination of the invention is carnosine, acetyl hexapeptide-8, palmitoyl pentapeptide-4, tetrapeptide-4 and palmitoyl tripeptide-8, which can tighten skin and reduce wrinkles within 14 days. The plant extract and the antioxidant component are added to act together, so that the repairing effect of the mask is further improved.
Description
Technical Field
The invention relates to the field of A61K8/9789, in particular to a water-light mask and a preparation method thereof.
Background
The facial mask is a kind of skin care product, and the skin is covered for a short time to temporarily isolate the external air and pollution, so that the skin cuticle is supplemented with all the moisture, humectant and nutrient in the facial mask. In recent years, because of the enhancement of the maintenance consciousness and the transition of the consumption consciousness of Chinese consumers, the consumer groups of the mask are continuously expanded, and at present, the mask becomes a heavy game in a cosmetic sales matrix because the mask bears the beauty of broad men and women consumers.
CN110559238A discloses a waxberry essence polypeptide water-light mask, which comprises a mask liquid coated on the surface of a substrate, wherein the mask liquid consists of a water solvent, a skin conditioning agent, a humectant, a thickening agent, a solubilizer and a PH regulator, the skin conditioning agent comprises poly-gamma sodium glutamate, a mixture of phycocyanin and alcohol, a cactus extract, a waxberry extract, trehalose, betaine, p-hydroxyacetophenone, hydroxyethyl cellulose, beta glucan and a polypeptide mixed liquid according to the content ratio of all raw materials, and the mask can relieve the dry and tight state of skin and nourish the skin in a water-moist manner, but the repairing function of the skin is still required to be further improved.
CN106265119B discloses a polypeptide tightening and moisturizing mask and a preparation method thereof, the components include: acetyl hexapeptide 3, trideceth 1, carnosine, aloe vera, milk yeast, butylene glycol, glycerol, sodium hyaluronate, squalane, tocopherol, yellow collagen, stearic acid, month Gui Chun polyether 3, phenoxyethanol, methylparaben, ethylparaben. The three cosmetic polypeptides of acetyl hexapeptide 3, tridecyl 1 and carnosine are important nutrition components of skin, can effectively improve facial skin relaxation, and can effectively supplement nutrition components such as amino acid and the like required by epidermal cells. However, the effect of the composition is not obtained in a short time, and the effect of tightening and removing wrinkles is still required to be further improved.
Disclosure of Invention
Aiming at the problems, the water-light facial mask provided by the invention is prepared from the following raw materials: water, moisturizer, skin conditioner, antioxidant component, plant extract, and skin protectant.
Preferably, the preparation raw materials comprise, by mass: 80-100 parts of water, 5-12 parts of humectant, 0.1-5 parts of skin conditioner, 0.0001-1 part of antioxidant component, 0.05-1 part of plant extract and 0.001-0.5 part of skin protectant.
In one embodiment, the humectant is selected from one or more of a small molecule humectant, a polymeric humectant, a closed oil.
Preferably, the humectant is a combination of a small molecular humectant and a high molecular humectant, and the mass ratio is (0.2-15): (0.01-2).
The small molecule moisturizers include, but are not limited to, butylene glycol, polyethylene glycol, propylene glycol, hexylene glycol, 1, 2-pentanediol, glycerin, maltitol, polypropylene glycol, sorbitol, mannitol, glycerol glucoside; preferably mannitol, butanediol, glycerol, 1, 2-pentanediol and glyceroglycosides, the mass ratio is (0.1-1): (1-6): (0.5-4): (0.1-1): (0.1-1).
The high molecular humectant comprises, but is not limited to, pullulan, tremella polysaccharide, beta-glucan, carob seed polysaccharide and hydrolyzed sclerotium gum; preferably hydrolyzed sclerotium rolfsii.
In one embodiment, the skin conditioning agent is selected from one or more of acids, plant essential oils, vitamins.
Preferably, the skin conditioning agent is a combination of acid and plant essential oil, and the mass ratio is (10-30): (0.1-2).
The acids include, but are not limited to, tetrahydropyrimidine carboxylic acid, hyaluronic acid, salicylic acid, tretinoin, preferably, tetrahydropyrimidine carboxylic acid.
The plant essential oil comprises, but is not limited to, lime peel oil, lavender oil, cedar oil, rose oil, jasmine oil, tea tree essential oil and lemon essential oil, preferably the combination of lime peel oil, lavender oil and cedar oil, and the mass ratio is (1-10): (0.1-5): (0.1-5).
In one embodiment, the antioxidant component is selected from one or more of a polysaccharide, a coenzyme, a polypeptide.
Preferably, the antioxidant component is a polypeptide.
The polypeptides include, but are not limited to, carnosine, acetyl hexapeptide-8, palmitoyl pentapeptide-4, tetrapeptide-4, palmitoyl tripeptide-8, nonapeptide-1, acetyl octapeptide-3, tripeptide-1, conopeptide, oligopeptide-1, tripeptide-1 copper, decarboxylated carnosine, palmitoyl tetrapeptide-7, acetyl dipeptide-1, lysine polypeptides, myristoyl hexapeptide-5, snake venom peptides, preferably carnosine, acetyl hexapeptide-8, palmitoyl pentapeptide-4, tetrapeptide-4, combinations of palmitoyl tripeptide-8, mass ratios of (3-18): (0.1-3): (0.01-2): (0.01-2): (0.01-4).
In one embodiment, the plant extract is selected from one or more of Ecklonia CAVA (Ecklonia CAVA) extract, cyrtymenia Sparsa (HIZIKIA FUSIFORME) extract, philippine Sonchus extract (CODIUM TOMENTOSUM), philippine Gelidium herb (GELIDIUM CARTILAGINEUM) extract, herba Portulacae (Portulaca oleracea) extract, green tea (Camellia sinensis) extract, herba Saussureae Involueratae (Saussurea species) extract, aloe (ALOE VERA) extract, centella asiatica (Centella asiatica) extract, grapefruit (Citrus PARADISI MACF) extract, and radix Puerariae (PUERARIAE LOBATAE RADIX) extract.
Preferably, the plant extract is a combination of thallus laminariae extract, cyrtymenia Sparsa extract, sargassum fusiforme extract, gelidium amansii extract, and herba Portulacae extract, and the mass ratio is (2-10): (2-10): (2-10): (2-10): 1.
in one embodiment, the emulsifier is selected from one or more of an ionic emulsifier, a nonionic emulsifier, a natural emulsifier.
Preferably, the emulsifier is a nonionic emulsifier.
Further preferably, the nonionic emulsifier is a combination of PPG-13-decyl tetradecyl polyether-24, coco glucoside, hydroxyethyl cellulose, polysorbate-60 and PEG-40 hydrogenated castor oil, and the mass ratio is (4-10): (2-8): (2-8): (0.001-1): (0.1-5).
In one embodiment, the skin protectant is selected from one or more of sodium lauroyl amino acid, jojoba oil, stearyl alcohol, shea butter, VE, peony root, aloe, centella asiatica, licorice, amino acids, dextran, allantoin, sodium hyaluronate, squalane, beta-alanyl hydroxypropionyl diaminobutyric acid benzylamine.
Preferably beta-alanyl hydroxyproline diaminobutyric acid benzylamine.
The bioactive polypeptide compound has the advantages of high bioactivity, easy absorption, safety and no toxicity, and the physiological effects and biological effects of beautifying and protecting skin and resisting aging are gradually applied to the beautifying cosmetics. The polypeptide combination in the invention is carnosine, acetyl hexapeptide-8, palmitoyl pentapeptide-4, tetrapeptide-4 and palmitoyl tripeptide-8, and the mass ratio is (3-18): (0.1-3): (0.01-2): (0.01-2): (0.01-4) can tighten skin and reduce wrinkles within 14 days, and the reasons considered by the applicant are: acetyl hexapeptide-8 can block nerve transmission muscle contraction information locally, influence the nerve conduction of the leather bag, relax the machine flesh of the face, palmitoyl pentapeptide-4 can penetrate the dermis to increase collagen, reverse the skin aging process through rebuilding from inside to outside, tetrapeptide and palmitoyl tripeptide-8 can increase collagen generation of the skin and fiber generation in extracellular matrix, reduce wrinkle depth, and the four polypeptides act together, so that the skin can be well repaired from the inside, obvious effect can be visually brought, the carnosine has good antioxidant, anti-saccharification and anti-inflammatory effects, redundant free radicals in the skin are removed, skin aging is reduced, skin elasticity is increased, skin moisturizing is kept, pigmentation is reduced, and the five polypeptides are combined according to the mass part requirements, so that the formed wrinkles can be reduced, the further generation of the wrinkles can be prevented from the source, and quick response is achieved in 14 days.
However, the polypeptide is unstable, especially when multiple polypeptides are compounded and used, the properties of the polypeptide can be changed when external conditions such as pH, temperature, illumination, oxygen concentration and the like are changed, so that the related efficacy performance of the water-based facial mask is affected, and the applicant finds that the small molecular humectant is a combination of mannitol, butanediol, glycerol, 1, 2-pentanediol and glyceroglycosides according to a mass ratio of (0.1-1): (1-6): (0.5-4): (0.1-1): (0.1-1), the stability of the polypeptide can be well ensured. The applicant believes that the possible reasons are that the polyhydric alcohol and sugar alcohol in the small molecule moisturizer can enable more water molecules to surround the polypeptide, so that an isolating protective layer is formed outside the polypeptide, the adsorption, aggregation and precipitation of the surface of the polypeptide are prevented, and the skin barrier is easier to permeate in the skin care process, so that the skin can absorb the polypeptide components better.
In one embodiment, the raw materials for preparing the hydrooptical mask further comprise, in parts by mass: 0.01-1 part of film forming agent, 0.00001-0.5 part of pH regulator and 0.1-5 parts of preservative.
In one embodiment, the film former is an oil soluble film former and/or a water soluble film former.
Preferably, the film forming agent is a water-soluble film forming agent.
Further preferably, the film former is polyacrylate crosslinked polymer-6.
In one embodiment, the pH adjuster includes, but is not limited to, sodium hydroxide, potassium hydroxide, triethanolamine, citric acid, sodium citrate, succinic acid, disodium succinate, sodium dihydrogen phosphate, disodium hydrogen phosphate, preferably disodium hydrogen phosphate.
In one embodiment, the preservative includes, but is not limited to, 1, 2-hexanediol, p-hydroxyacetophenone, hexetidine, imidazolidinyl urea, sorbic acid, 2-furoic acid, captan, diglyme, hexeneglycol, benzalkonium chloride, chlorhexidine, benzoic acids, chlorocresol, cresols, nipagins, t-butanol, benzalkonium chloride, benzethonium chloride, carbomers, cetrimide, bronopol, chlorhexidine, butyl hydroxybenzene, methylparaben, propyl hydroxybenzoate, ethylparaben, p-chloro-meta-xylene, phenoxyethanol, sodium propionate, preferably 1, 2-hexanediol, p-hydroxyacetophenone, carbomer, in a mass ratio of (1-10): (0.5-8): (0.5-5).
The invention also discloses a preparation method of the water-light facial mask, which comprises the following steps: mixing the raw materials.
Specifically, the method comprises the following steps:
(1) In a main emulsifying pot, 80% of the total water is taken, then one half of butanediol, one third of glycerol, hydrolyzed small sclerotium gum, polyacrylate crosslinked polymer-6, carbomer, hydroxyethyl cellulose, disodium hydrogen phosphate and polysorbate-60 are sequentially added, stirring and homogenizing are started for 1-2min until no particles exist, heating is carried out to 80-85 ℃, and heat preservation is carried out for 25-30 min.
(2) Dissolving five sixths of 1, 2-hexanediol and p-hydroxyacetophenone in a container at 60-70 ℃ for standby application.
(3) Uniformly mixing PEG-40 hydrogenated castor oil, lime peel oil, lavender oil and cedar wood oil for later use.
(4) Cooling the main emulsifying pot to 60-70 ℃, adding the solution uniformly mixed in the step (2), and uniformly stirring.
(5) Cooling to 40-45 ℃, adding the rest raw materials, stirring uniformly, adding the solution uniformly mixed in the step (3), and stirring uniformly.
Advantageous effects
1. The polypeptide combination of the invention is carnosine, acetyl hexapeptide-8, palmitoyl pentapeptide-4, tetrapeptide-4 and palmitoyl tripeptide-8, which can tighten skin and reduce wrinkles within 14 days.
2. Beta-alanyl hydroxy prolyl diaminobutyric acid benzylamine is used as a skin protective agent, can promote proliferation of fibroblasts and horny layer cells, improve cell viscosity, increase synthesis of type I collagen, reduce expression of elastase, and endow skin with better compactness, so that the compacting effect is further improved.
3. The humectant is a combination of a small molecular humectant and a high molecular humectant, so that the mask has good moisture retention and is easier to continuously absorb beneficial components.
4. The plant extract and the antioxidant component are added to act together, so that the repairing effect of the mask is further improved.
5. The mask liquid is stable and has long shelf life by compounding a plurality of nonionic emulsifiers, so that the beneficial components can play a role.
Detailed Description
Example 1
The hydrolyzed ringlet gum was purchased from Shanghai Hui Biotechnology Co. The carnosine is purchased from Shenzhen Viqi technologies Inc.
The carbomers were purchased from road-blogging management (Shanghai) Inc. The polyacrylate crosslinked polymer-6 was purchased from SEPPIC s.a. The sargassum fusiforme extract is purchased from Guangzhou Bai Hao chemical industry Co. The Pinus sylvestris extract was purchased from Fangzhou Bai Hao chemical Co.
The thallus laminariae extract is purchased from Guangzhou Bai Hao chemical industry Co. The gelonin extract was purchased from chemical industry limited, baobao, guangzhou.
The PPG-13-decyl tetradecyl polyether-24 is available from Ashland LLC.
The coco glucoside was purchased from basf (china) limited.
The hydroxyethyl cellulose was purchased from taiwan technical ja refinement trade limited.
The purslane extract was purchased from BioSpectrum, inc.
The beta-alanyl hydroxypropionyl diaminobutyric acid benzylamine was purchased from Vichi technologies Inc. of Shenzhen.
The PEG-40 hydrogenated castor oil was purchased from Basiff (China) Inc.
The acetyl hexapeptide-8 is purchased from Shenzhen Vichi technologies Co.
The palmitoyl pentapeptide-4 is purchased from Shenzhen Vichi technologies Inc.
The lime peel oil was purchased from pure elegant fragrance essence limited.
The lavender oil was purchased from pure elegant fragrance essence limited.
The tetrapeptide-4 is purchased from Shenzhen Vichi technologies Inc.
The cedar wood oil was purchased from pure elegant fragrance and essence limited.
The palmitoyl tripeptide-8 is purchased from Shenzhen Vichi technologies Co., ltd.
The polysorbate-60 is available from Shenzhen Vichi technologies Inc.
The preparation method of the water-light facial mask comprises the following steps:
(1) In a main emulsifying pot, 80% of the total water is taken, then one half of butanediol, one third of glycerol, hydrolyzed small sclerotium gum, polyacrylate crosslinked polymer-6, carbomer, hydroxyethyl cellulose, disodium hydrogen phosphate and polysorbate-60 are sequentially added, stirring and homogenizing are started for 1-2min until no particles exist, heating is carried out to 80 ℃, and the temperature is kept for 30 min.
(2) Five sixths of 1, 2-hexanediol and p-hydroxyacetophenone are heated and dissolved in a container at 65 ℃ for standby.
(3) Uniformly mixing PEG-40 hydrogenated castor oil, lime peel oil, lavender oil and cedar wood oil for later use.
(4) Cooling the main emulsifying pot to 65 ℃, adding the solution uniformly mixed in the step (2), and uniformly stirring.
(5) Cooling to 40 ℃, adding the rest raw materials, stirring uniformly, adding the solution uniformly mixed in the step (3), and stirring uniformly.
Performance testing
1. Stability test: the water light mask liquid prepared in the example 1 is placed in a 50 ℃ incubator for 24 hours, and then taken out, and the product is observed to be not layered, not crystallized and good in stability.
2. Cosmetic tightening and anti-wrinkle efficacy test: according to QB/T4256-2011 cosmetic moisturizing efficacy evaluation guidelines; T/ZHCA003-2018 cosmetic affects the transepidermal water loss test method; T/TDCA003-2021 cosmetic tightening efficacy test method; a clinical evaluation method for improving the canthus line efficacy of a T/SHRH018-2019 cosmetic; liu Weiyi. Zhou Lin. Zhao Hua cosmetic efficacy evaluation (XII) -consumer use test [ J ] daily chemical industry, 2021, 51 (06): 485-490.
The detection method comprises the following steps:
healthy, dry facial skin, lack of moisture, poor skin barrier function, loose skin and lack of elasticity, fine lines or wrinkles in the corners of the eyes, 31 subjects in chinese healthy men/women according to classification 2 to 5 of SKINAGEINGATLAS, aged range 25-60 years. The moisture content of the stratum corneum, skin elasticity of the subject were measured and a partial photograph was taken before using the test product, continuously using the product of example 1 for 14 days, and for 28 days, respectively, using the method of the front and rear controls. The evaluation results before and after the product is used are compared by a statistical test method so as to judge whether the statistical difference exists.
Detection part:
(1) Skin stratum corneum moisture content-cheek;
(2) Skin elasticity R2-cheek;
(3) Primos-CR corner of eye wrinkle length-corner of eye;
(4) Primos-CR canthus wrinkle volume-canthus;
(5) Primos-CR canthus wrinkle count-canthus;
(6) Self-assessment-full face.
Detection result:
sample completion: group 31 subjects were enrolled, 30 subjects were eventually counted, and subjects numbered VT022 were enrolled for personal reasons, with 2 men, 28 women, ages 28 to 55 years, and average ages 44.77±1.42 years. After the face is cleaned, the mask of the embodiment 1 is aligned to eyes, lips are applied to dry the face, the mask cloth is attached, after 15 minutes, the mask is taken down, the skin of the face is gently massaged, and after the massage is finished, the face is cleaned by clear water for 1 time every other day.
Product usage and tolerability feedback conditions: each subject used the test sample as required within the prescribed time, and showed no adverse reaction according to the adverse reaction recording results according to 2015 edition of cosmetic safety technical Specification.
The moisture content of the skin horny layer is shown in the following table:
TABLE 1 moisture content of the stratum corneum of skin
Product(s) | Basic value | The product is used for 14 days | The product is used for 28 days |
Example 1 | 44.71±2.46 | 75.46±1.52 | 72.01±1.31 |
TABLE 2 moisture content improvement Rate of skin stratum corneum
Skin elasticity R2 is shown in the following table:
TABLE 3 skin elasticity R2 test results
Product(s) | Basic value | The product is used for 14 days | The product is used for 28 days |
Example 1 | 57.63±1.16 | 66.67±1.38 | 64.25±1.18 |
TABLE 4 skin elasticity R2 improvement Rate
Product(s) | The product is used for 14 days | The product is used for 28 days |
Example 1 | 15.68% | 11.48% |
Primos-CR canthus wrinkle count is shown in the following Table:
TABLE 5 Primos-CR canthus wrinkle count
Product(s) | Basic value | The product is used for 14 days | The product is used for 28 days |
Example 1 | 5.00±0.12 | 3.50±0.17 | 3.10±0.21 |
TABLE 6 Primos-CR canthus wrinkle improvement Rate
Product(s) | The product is used for 14 days | The product is used for 28 days |
Example 1 | 30.00% | 38.00% |
Primos-CR canthus wrinkle volumes are shown in the following table:
TABLE 7 Primos-CR canthus wrinkle volumes
Product(s) | Basic value | The product is used for 14 days | The product is used for 28 days |
Example 1 | 8.19±0.43 | 7.18±0.49 | 6.52±0.52 |
TABLE 8 Primos-CR canthus wrinkle volume improvement Rate
Product(s) | The product is used for 14 days | The product is used for 28 days |
Example 1 | 12.23% | 20.38% |
Primos-CR canthus wrinkle lengths are shown in the following Table:
TABLE 9 Primos-CR canthus wrinkle Length
Product(s) | Basic value | The product is used for 14 days | The product is used for 28 days |
Example 1 | 40.43±2.51 | 36.67±2.11 | 35.87±2.35 |
TABLE 10 Primos-CR canthus wrinkle Length improvement Rate
Product(s) | The product is used for 14 days | The product is used for 28 days |
Example 1 | 9.32% | 11.29% |
For 28 days of continuous use of the test product, 96.67% of subjects felt the product to have a tightening effect after use; 86.67% of the subjects feel anti-wrinkle efficacy after use of the product; 100.00% of subjects feel the product has moisturizing effect after using, 90.00% of subjects feel the product can improve the compactness of facial skin after using; 96.67% of subjects feel the product to be used, the facial skin elasticity can be enhanced, 86.67% of subjects feel the product to be used, and the effect of reducing wrinkles is achieved; 93.33% of subjects feel the product improved skin smoothness after use; 100.00% of the subject sensory products can achieve the effect of moisturizing the skin, 96.67% of the subject sensory products are easy to absorb; 90.00% of subjects feel the product as good in skin feel; 100.00% of subjects considered the product to be mild and non-irritating; 100.00% of the subjects were satisfied with the overall product.
Claims (10)
1. The water-light facial mask is characterized by comprising the following preparation raw materials: water, moisturizer, skin conditioner, antioxidant component, plant extract, and skin protectant.
2. The hydrographic mask of claim 1, wherein the moisturizer is selected from one or more of a small molecule moisturizer, a high molecule moisturizer, and a occlusive oil.
3. The water-light facial mask according to claim 2, wherein the humectant is a combination of a small molecular humectant and a high molecular humectant, and the mass ratio is (0.2-15): (0.01-2).
4. The hydrographic mask of claim 1, wherein the skin conditioning agent is selected from one or more of acids, plant essential oils, vitamins.
5. The hydrographic mask of claim 1, wherein the antioxidant component is selected from one or more of a polysaccharide, a coenzyme, a polypeptide.
6. The hydrographic mask of claim 5, wherein the polypeptide is a combination of carnosine, acetyl hexapeptide-8, palmitoyl pentapeptide-4, tetrapeptide-4, palmitoyl tripeptide-8, in a mass ratio of (3-18): (0.1-3): (0.01-2): (0.01-2): (0.01-4).
7. The hydrographic mask of claim 1, wherein the plant extract is selected from one or more of kelp extract, sargassum fusiforme extract, pinus maladsura extract, gelonin extract, purslane extract, green tea extract, saussurea involucrata extract, aloe extract, centella extract, grapefruit extract, kudzuvine root extract.
8. The hydrographic mask of claim 1, wherein the emulsifier is selected from one or more of an ionic emulsifier, a nonionic emulsifier, a natural emulsifier.
9. The hydrographic mask according to any one of claims 1-8, wherein the hydrographic mask further comprises: film forming agent, pH regulator and antiseptic.
10. A method of preparing a hydrographic mask according to claim 9, comprising the steps of: mixing the raw materials.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310853358.8A CN116889528A (en) | 2023-07-12 | 2023-07-12 | Water-light mask and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310853358.8A CN116889528A (en) | 2023-07-12 | 2023-07-12 | Water-light mask and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116889528A true CN116889528A (en) | 2023-10-17 |
Family
ID=88314510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310853358.8A Pending CN116889528A (en) | 2023-07-12 | 2023-07-12 | Water-light mask and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116889528A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117357450A (en) * | 2023-12-08 | 2024-01-09 | 珠海金肽生物科技有限公司 | Composition for improving skin aging relaxation and preparation method and application thereof |
-
2023
- 2023-07-12 CN CN202310853358.8A patent/CN116889528A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117357450A (en) * | 2023-12-08 | 2024-01-09 | 珠海金肽生物科技有限公司 | Composition for improving skin aging relaxation and preparation method and application thereof |
CN117357450B (en) * | 2023-12-08 | 2024-04-16 | 珠海金肽生物科技有限公司 | Composition for improving skin aging relaxation and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3881819A1 (en) | Two-dosage-form essence and preparation method therefor | |
CN109157453B (en) | Skin-friendly sustained-release composition and cosmetic thereof | |
WO2021003962A1 (en) | Skincare composition for repairing skin, and preparation method therefor | |
CN110664644B (en) | Skin care composition containing folic acid, essence and preparation method thereof | |
CN109700687B (en) | Flexible liposome cosmetic containing active polypeptide and preparation method thereof | |
CN112656713A (en) | Cosmetic composition containing hyaluronic acid and/or derivatives thereof, and preparation method and application thereof | |
CN110897995A (en) | Whitening cream and preparation method thereof | |
CN109394645B (en) | Smearing type water acupuncture essence and preparation method thereof | |
CN113616566A (en) | Skin care essence for tightening skin and preparation method thereof | |
CN114848541A (en) | Anti-aging and wrinkle-removing composition and preparation method thereof, and cosmetic and preparation method thereof | |
CN116889528A (en) | Water-light mask and preparation method thereof | |
CN111743836A (en) | Soothing and repairing mask liquid, preparation method thereof and freeze-dried mask containing soothing and repairing mask liquid | |
WO2020244167A1 (en) | Cellular energy repair composition | |
CN110721148A (en) | Multidirectional pulling and tightening polypeptide essence and preparation method thereof | |
CN107440932B (en) | Skin care product composition containing folic acid, facial mask and preparation method of facial mask | |
CN109172422B (en) | Hyaluronic acid mask liquid and preparation method thereof | |
CN114931543A (en) | Repair anti-aging essence with high content of blue copper peptide and preparation method thereof | |
CN110693778A (en) | Face cream and production process thereof | |
CN108403609B (en) | Firming, skin-moistening and face-cleaning gel | |
CN113633575A (en) | Skin color brightening composition and preparation method of essence thereof | |
CN112773761A (en) | Cosmetic composition, essence and preparation method thereof | |
CN116172891B (en) | Multi-effect moisturizing composition and preparation method thereof | |
CN109528579B (en) | Moisturizing and repairing emulsion spray and preparation method thereof | |
CN116549307A (en) | Nerve-soothing and soothing type eye and lip cleansing lotion and preparation method thereof | |
CN115006303A (en) | Anti-allergy moisturizing skin-activating essence lotion and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |